TearLab Corporation (TEAR)
-NasdaqCM | Prev Close: | 12.33 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 16.80 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | 11-Nov-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 3.65 - 15.18 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 771,053 |
|---|
| Market Cap: | 405.51M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- TEARLAB CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Tue, Oct 1)
- InPlay: TearLab announces appointment of Seph Jensen as the co's President and Chief Operating OfficerBriefing.com(Tue, Oct 1)
- Former Alcon Executive Joins TearLab as President & COOGlobeNewswire(Tue, Oct 1)
- TearLab to Participate in Craig-Hallum's 4th Annual Alpha Select ConferenceGlobeNewswire(Thu, Sep 19)
- TEARLAB CORP FinancialsEDGAR Online Financials(Tue, Aug 20)
- 3 Health Care Stocks Rising on Unusual Volumeat TheStreet(Thu, Aug 15)
- TEARLAB CORP Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Wed, Aug 14)
- TearLab Corporation's CEO Discusses Q2 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Aug 13)
- TEARLAB CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Tue, Aug 13)
- TearLab Corporation Reports Q2-13 Financial ResultsGlobeNewswire(Tue, Aug 13)
- Q2 2013 TearLab Corp Earnings Release - After Market CloseCCBN(Tue, Aug 13)
- 5 Earnings Stocks Everyone Hates -- but You Should Loveat TheStreet(Mon, Aug 12)
- Tearlab Earnings: What Investors Should Watchat Wall St. Cheat Sheet(Sun, Aug 11)
- TearLab to Participate in the Canaccord Genuity 33rd Annual Growth ConferenceGlobeNewswire(Wed, Aug 7)
- Investigations into Orthofix International N.V., AdCare Health Systems, Inc., and TearLab Corp. Announced by Holzer Holzer & Fistel, LLCBusiness Wire(Mon, Aug 5)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| TEAR | 0.00% | 405.51M |
| TMO | 0.00% | 33.47B |
| A | 0.00% | 17.17B |
| WYETH.BO | 0.03% | 13.14B |
| WYETH.NS | 0.71% | 13.08B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 45.97 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.52 |
|---|
| Quarterly EPS Est
(Sep-13)
: | -0.14 |
|---|
| Mean Recommendation*: | 1.4 |
|---|
| PEG Ratio (5 yr expected): | -0.72 |
|---|
Business Summary
TearLab Corporation operates as an ophthalmic device company. It engages in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of d...
View More